Odaban

Odaban is a British antiperspirant brand specialising in treatments for excessive sweating (hyperhidrosis). It was created in the early 1970s by a pharmacist who developed an aluminium-chloride spray for a hospital nurse troubled by severe perspiration, and it has since been sold over the counter through UK pharmacies for several decades [9]. The brand is owned by MDM Healthcare Ltd., a company registered in England and Wales, while its products are manufactured in Germany [3]. It remains an actively trading family business, currently run by the founder's son alongside business partners.

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

According to the company's own account, the Odaban story began when a young pharmacist set out to help an operating-room nurse who was suffering from severe sweating. After roughly six months of research, carried out with the nurse, he arrived at a formula that resolved her condition, and that product became Odaban [9]. The brand dates this development to the early 1970s; its packaging and website carry the line "proven since 1970" [8].

Sources differ on the founder's name. The company's German-market "Odaban Story" identifies him as pharmacist Jeff Bracey [9], whereas the main site's history page renders the name as "Dan Bracy" [1]. The family surname is recorded as Bracey in the company's legal notice, where a Daniel Bracey is listed among the managing directors [3]; the German account describes the founder handing leadership to his son Daniel, which places Daniel as a successor rather than the original founder.

Odaban is operated by MDM Healthcare Ltd., registered in England and Wales (company number 6570252) and based at Wilmslow, England [3]. The legal notice lists three managing directors: Marcus Fritze, Daniel Bracey and Marco Hülsbeck. The German "Odaban Story" frames the company as a family business, the founder having transferred its running to his son and business partners.

The brand's country of origin is sometimes blurred by its manufacturing arrangements. Odaban presents itself as developed and manufactured "in the UK & Germany" [8], and several pages describe the products as "made in Germany". The operating company, however, is British, and the company's history situates the original development as a milestone "in the fight against sweating problems in the United Kingdom". The German element refers to current production: the US FDA's DailyMed registry records the manufacturer as RYMA PHARM GmbH and the labeller as Archifox GmbH & Co. KG, both in Körle, Germany [10].

Odaban's range centres on a clinical-strength antiperspirant spray, supported by a gel, wipes, a daily deodorant stick, and a foot-and-shoe powder. The active ingredient across the line is aluminium chloride. The company explains that, applied to dry skin overnight, the aluminium chloride combines with proteins on the skin's surface to form an insoluble bond that acts as a plug, partly blocking the sweat ducts. The DailyMed listing, which classifies the spray as a human over-the-counter drug, records the concentration as 14.5% aluminium chloride — a figure the brand's own pages do not state [10].

The company says its formulas are vegan and cruelty-free, and that the products have been rated "very good" by the dermatological testing service dermatest [6]. It also addresses the long-running safety debate around aluminium antiperspirants directly, stating that aluminium-containing antiperspirants are safe according to current scientific studies and that the aluminium-protein complex is too insoluble for the metal to be absorbed into the body [2][6].

Odaban is active. It trades through e-commerce sites for the UK and German markets, maintains social-media channels, and continues to be distributed through UK pharmacies. The company says it has served over 250,000 customers and reaches more than 100 countries [1]. The business is still run as a family company under the founder's son, Daniel Bracey, with the day-to-day operating entity remaining MDM Healthcare Ltd. in England.